Market revenue in 2023 | USD 134.3 million |
Market revenue in 2030 | USD 213.7 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.99% in 2023. Horizon Databook has segmented the South Korea regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is one of the largest markets in Asia Pacific along with Japan, China, and India. The medical device market is dependent on imports as low-end medical devices are manufactured in the country.
High-end medical devices are imported from North America, Asia, and Europe. The medical equipment imports from these three regions account for 60.0% of the total market demand, with the U.S. holding the largest share among the three.
Companies exporting med-tech equipment to South Korea require appointment of a representative or an importer to ensure regulatory compliance & gain medical device approval. The demand for legal representation services is expected to increase owing to growing import of medical devices.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account